Related Experiment Videos
Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints
I D Pogozheva1, A L Lomize, H I Mosberg
1College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109 USA.
Biophysical Journal
|July 24, 1998
Summary
Researchers modeled opioid receptor structures, revealing conserved binding pockets crucial for drug specificity. These findings explain how different opioid ligands interact with delta, mu, and kappa receptors.
Area of Science:
- Structural biology
- Computational chemistry
- Pharmacology
Background:
- Opioid receptors are G-protein coupled receptors (GPCRs) that mediate pain relief and other physiological effects.
- Understanding the three-dimensional structures of opioid receptors is essential for designing subtype-selective drugs.
- Previous models of rhodopsin-like GPCRs provide a foundation for opioid receptor structure prediction.
Purpose of the Study:
- To calculate the three-dimensional structures of delta, mu, and kappa opioid receptors.
- To identify conserved and variable regions within the ligand-binding pockets.
- To elucidate the binding interactions of various opioid ligands with their respective receptors.
Main Methods:
- Utilized distance geometry algorithms to model receptor structures.
- Incorporated hydrogen bonding constraints based on a general model for GPCRs.
- Fit diverse opioid agonists and antagonists into the calculated binding pockets.
Main Results:
- Opioid receptor structures exhibit extensive interhelical hydrogen bonding networks.
- A conserved inner binding region and a variable outer region were identified.
- Ligands display a consistent spatial arrangement, with specific interactions at the pocket's bottom and periphery.
Conclusions:
- The conserved residues in the binding pocket are critical for ligand interaction.
- The variable residues are responsible for subtype selectivity among delta, mu, and kappa receptors.
- The structural model provides a framework for understanding opioid pharmacology and drug design.